Language

Region

Marketplace Donate Now Become a Member

Cart (0)

CNCC

May 15, 2016 8:30 AM - May 18, 2016 5:30 PM

Beijing Chaoyang, 100062 Beijing, China

DIA China 8th Annual Meeting

Overview

The DIA China Annual Meeting as the largest interdisciplinary event in Asia that brings together a global network of life sciences professionals to foster innovation that leads to the development of safe and effective products and therapies to patients.

Professionals at all levels involved in the drug discovery, development, and life cycle management of health care products, will travel from China and around the world to share their views, knowledge, experience, and cross-functional content with real-world application.

DIA China Annual Meeting had attracted nearly 1900 attendees in 2015 and will continue to be your essential partner to update knowledge and help to accelerate heath care product development.

Register

Featured topics

CFDA Townhall

Special Forum – Enabling Key Capability for Innovation in China

Rapid Evolving China Regulatory Science – Seize the Opportunity for Driving Innovation

Develop Innovative Solution to Fill the Unmet Medical Needs in China – Special Focuses on Oncology, Diabetes, Cardiovascular and HCV/HBV

Operational Excellence – China’s Own Challenges and Unique Opportunity

Clinical Trial Sites in China – Bottleneck or the Anchor for Quality Clinical Trials

Quantitative Science – The Backbone of Evidence Based Data Generation

CMC & Generic Drug

Biologics & Biosimilar Development

Medical Affairs – MSLs, Marketing New Model Engagement, Compliance and Market Access

Key Elements in Successful Drug Activities – Medical Writing and Project Management

Safety Surveillance

Quality System – from the Regulator, Site and Investigator's Perspectives

Early Stage Drug Development

CRO, SMO & Investigator

Informational Technology -- Long Distance, Mobile Medicine & Documentation

Hot Topics and Late Breaker – Medical Devices and Rare Diseases

Program Committee

Jingsong Wang, MD Founder, Chairman, and Chief Executive Officer
Harbour BioMed, China
Haifeng Cao Regulatory Affairs Director
Boehringer Ingelheim Co. Ltd, China
Lili Cao, MS Deputy Director
China Center for Food and Drug International Exchange, National Medical Products, China
Xiaochun Cao
TIGERMED CO.,LTD., China
George Chen, MD, MBA Senior VP, Global Medicines Development, Head of China Development Unit
AstraZeneca China, China
Paul Dai, MD Head of Clinical Operations
TDC, Asia, Takeda, China
Yazhong Deng, MBA CEO and Founder
Beijing Trust Medical Consulting Co. Ltd, China
Frank Fan, PhD Senior Medical Director
Sanofi, China
Tony Guo Executive Director, Head of Biometrics China
BeiGene, China
Min Wang Irwin, MD, PhD Venture Partner
Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd., China
Amy Jiang Head of Quality Office
Harbour Biomed, China
Helen Li, MD, MBA Director, Emerging Market QA Asia Lead
Pfizer Medical, China
Joy Li Director of pharmacovigilance and medical information
BMS China R&D, China
Shuting Li, MD Deputy Director
GCP Alliance, China, China
Vera Liang, MD Sr. Director, Drug Safety Unit Regional Head - APAC
Pfizer (China) R&D Co., Ltd., China
Jane LIN, MD VP, Strategic Medical Affairs
Johnson & Johnson Medical (China) Ltd., China
Melly Lin, MS CMC Regulatory Policy Lead, Pharma Technical Regulatory
F. Hoffmann-La Roche Ltd, Switzerland
Jessica Liu, MD Senior Consultant
Beijing Taya Ltd, China
Roger (Peng) Qu, PhD Head of Clinical Statistics
Pfizer China R&D Center, China
Hualong Sun General manager
Meta Clinical Technical Co. Ltd, China
Xiaoling Wang Clinical Documentation
Clinical Science Operation, Sanofi R&D China, China
Xiuqin Wang, MD Vice Director of Scientific Research Dept.
Jiangsu Province Hospital, China
Jielai Xia, PhD Director, Department of Medical Statistics
Air Force Military Medical University, China
Jack Xu, MD, MS Senior Vice President
Shanghai Clinical Research Center (SCRC), China
Charles Yan Vice President, Head of Clinical Data Science Center
Jiangsu Hengrui, China
James Yan Executive Vice President, Head of Early Development and Drug Safety,
Zai Lab, China
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China
Joe Zhang Co-founder and CEO
BJ Bioscience Inc., China
Mingping Zhang Vice President, Technical
PAREXEL, United States
Ling Zhen
Quintiles, China
Xiaoxiang Chen Vice President
Boehringer Ingelheim Shanghai Pharm. Co. Ltd, China
Carol Zhu, MBA Vice President, Portfolio and Project Management
JW Therapeutics, China
Janet Lv, MS, RPh Senior Consultant, Roche Pharma Product Development China
Roche , China
Ling Su, PhD Research Fellow
Shenyang Pharmaceutical University, Yeehong Business School, China
Ning Xu, MD, MBA Executive Vice President, Head of Global Clinical Operations, Zailab
Zai Lab, China

Have an account?

DIA China 8th Annual Meeting

Overview

Featured topics

Program Committee

Be informed and stay engaged.